STAT3 and hepatocellular carcinoma: Siddharth et al. further demonstrated that metformin and sorafenib led to a significant inhibition of HCC cell growth and induced apoptosis compared to either drug alone, suppressing the MAPK/ERK/Stat3 signaling pathway [101].